Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Unisys
UIS
$209M
| $2.99M | ﹤0.01% |
584,840
-47,285
| -7% | -$297K |
|
|
PTRA
2627
DELISTED
Proterra Inc. Common Stock
PTRA
| $2.99M | ﹤0.01% |
792,037
-14,146
| -2% | -$74.8K |
|
|
SP
2628
DELISTED
SP Plus Corporation
SP
| $2.98M | ﹤0.01% |
85,722
-6,729
| -7% | -$232K |
|
2629
Immunovant
IMVT
$8.64B
| $2.97M | ﹤0.01% |
167,510
+17,836
| +12% | +$225K |
|
2630
First Bancorp
FNLC
$402M
| $2.97M | ﹤0.01% |
99,288
+2,800
| +3% | +$83.9K |
|
2631
Business First Bancshares
BFST
$1.05B
| $2.97M | ﹤0.01% |
134,239
+19,190
| +17% | +$440K |
|
|
MCBC
2632
DELISTED
Macatawa Bank Corp
MCBC
| $2.97M | ﹤0.01% |
268,974
+9,158
| +4% | +$97.3K |
|
2633
Treace Medical Concepts
TMCI
$312M
| $2.96M | ﹤0.01% |
128,825
+27,443
| +27% | +$632K |
|
2634
Biohaven
BHVN
$2.21B
| $2.96M | ﹤0.01% |
+213,201
| New | +$3.01M |
|
2635
Cadre Holdings
CDRE
$1.46B
| $2.96M | ﹤0.01% |
146,932
+95,621
| +186% | +$2.46M |
|
|
MTTR
2636
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $2.96M | ﹤0.01% |
1,055,786
-6,118
| -0.6% | -$19.6K |
|
2637
Capital City Bank Group
CCBG
$898M
| $2.95M | ﹤0.01% |
90,840
+9,843
| +12% | +$335K |
|
2638
Amalgamated Financial
AMAL
$1.53B
| $2.95M | ﹤0.01% |
127,956
+15,408
| +14% | +$373K |
|
2639
LegalZoom.com
LZ
$963M
| $2.94M | ﹤0.01% |
380,414
+44,828
| +13% | +$389K |
|
2640
Amplify Energy
AMPY
$198M
| $2.94M | ﹤0.01% |
334,872
+209,645
| +167% | +$1.78M |
|
|
BELFB
2641
Bel Fuse Inc Class B
BELFB
$4.19B
| $2.94M | ﹤0.01% |
89,368
+14,902
| +20% | +$487K |
|
2642
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $2.94M | ﹤0.01% |
39,404
+13,789
| +54% | +$1M |
|
2643
Miller Industries
MLR
$645M
| $2.91M | ﹤0.01% |
109,285
+10,313
| +10% | +$264K |
|
2644
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.48B
| $2.91M | ﹤0.01% |
26,917
-22,919
| -46% | -$2.52M |
|
2645
Hims & Hers Health
HIMS
$6.57B
| $2.9M | ﹤0.01% |
452,382
+78,157
| +21% | +$445K |
|
|
OLPX
2646
DELISTED
Olaplex Holdings
OLPX
| $2.9M | ﹤0.01% |
556,516
+208,248
| +60% | +$1.24M |
|
|
DCPH
2647
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.88M | ﹤0.01% |
175,507
+5,579
| +3% | +$90.7K |
|
2648
Citizens & Northern Corp
CZNC
$466M
| $2.88M | ﹤0.01% |
125,819
-3,931
| -3% | -$94.1K |
|
2649
First Trust Rising Dividend Achievers ETF
RDVY
$25.8B
| $2.87M | ﹤0.01% |
65,360
+28,278
| +76% | +$1.24M |
|
2650
Kura Oncology
KURA
$964M
| $2.86M | ﹤0.01% |
230,665
+2,004
| +0.9% | +$29.1K |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.